A cell-based alternative to the mouse potency assay for pharmaceutical type E botulinum antitoxins
The pharmacopeia mouse neutralization assay (PMNA) is the standard method for determining the potency of pharmaceutical botulinum antitoxins. However, a PMNA requires a large number of mice, and, thus, an alternative in vitro method to replace it is ...
Eran Diamant +11 more
doaj +6 more sources
Equine botulinum antitoxin for the treatment of infant botulism. [PDF]
ABSTRACTInfant botulism is the most common form of human botulism in Argentina and the United States. BabyBIG (botulism immune globulin intravenous [human]) is the antitoxin of choice for specific treatment of infant botulism in the United States. However, its high cost limits its use in many countries.
Vanella de Cuetos EE +6 more
europepmc +4 more sources
Clinical characteristics and predictors of prolonged hospitalization in patients with cosmetic botulinum toxin poisoning: a retrospective cohort study [PDF]
BackgroundThe increasing cosmetic use of botulinum toxin has been accompanied by poisoning events related to inappropriate administration, including excessive dosing, unapproved or unverifiable products, self-injection, and procedures performed outside ...
Yu-quan Chen +5 more
doaj +2 more sources
Neutralization of Tetanus Neurotoxin with Various Botulinum Antitoxins (A-F) in a Study to Isolate Clostridium botulinum from Field Samples [PDF]
In a study to isolate Clostridium botulinum from field samples, 53 C. botulinum-like isolates were found neutralizable by botulinum antitoxins using the standard mouse bioassay. The neutralization results of 14 of them were found false-positive due to contamination with C.
Saeed, E. M. A. +2 more
core +5 more sources
Wound Botulism Complicating a Snake Bite Wound Following Traditional Application of Raw Goat Skin Successfully Treated with Botulinum Antitoxin: A Case Report [PDF]
Ahmad Shekaib Rasikh,1 Mohammad Maroof Aram,2 Abdul Tawab Noory,1 Aminulhaq Sarwary1 1Department of Infectious Diseases, Ali Abad Teaching Hospital, Kabul University of Medical Sciences, Kabul, Afghanistan; 2Department of Internal Medicine, Ali Abad ...
Rasikh AS, Aram MM, Noory AT, Sarwary A
doaj +2 more sources
Summary: Botulinum neurotoxin (BoNT) is one of the most acutely lethal toxins known to humans, and effective treatment for BoNT intoxication is urgently needed.
Kwok-ho Lam +8 more
doaj +3 more sources
Iatrogenic botulinum Toxin Type A poisoning with persistent unilateral vocal cord paralysis: a case report and clinical implications [PDF]
With the continuous advancement of medical aesthetic technologies, botulinum toxin injection has emerged as a prevalent method for wrinkle removal and facial enhancement. However, improper administration can result in botulism incidents.
Shizhao Xiang, Yu Du, Yu Du
doaj +2 more sources
Therapeutic efficacy of equine botulism antitoxin in Rhesus macaques. [PDF]
There are currently no licensed vaccines available for prevention of botulism in humans. The vaccination is not desirable due to expanding therapeutic indications of botulinum toxins.
Shantha Kodihalli +6 more
doaj +2 more sources
A Case of Botulism Fast Adjusting with Antitoxin Administration in the Early Period and the Use of Electromyography in Diagnosis [PDF]
Botulism is a rare but potentially life-threatening neuroparalytic syndrome caused by the action of a neurotoxin caused by the bacterium Clostridium botulinum. Early diagnosis and early treatment is important. In cases where botulism occurs sporadically,
Edin Botan +8 more
doaj +2 more sources
Botulism in Spain: Epidemiology and Outcomes of Antitoxin Treatment, 1997–2019 [PDF]
Background: Botulism is a low incidence but potentially fatal infectious disease caused by neurotoxins produced mainly by Clostridium botulinum.
Marina Peñuelas +8 more
doaj +3 more sources

